New Current Report Filed with the SEC Relating to Statement that Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review Should Not Be Relied Upon: 8-K – CTT PHARMACEUTICAL HOLDINGS, INC. (0001035422) (Filer)

A current report on Form 8-K was just filed with the U.S. Securities & Exchange Commission (SEC) relating to a statement that certain of the company’s previously-issued financial statements or a related audit report or completed interim review should not be relied upon by investors or other interested parties. Details of the current report are:

8-K – CTT PHARMACEUTICAL HOLDINGS, INC. (0001035422) (Filer)
Filed: 2015-11-03 AccNo: 0001553350-15-001141 Size: 13 KB

Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Filing Date: 2015-11-03T15:10:16-05:00

This is a breaking news story. You can access the complete current report through the SEC’s Edgar system: http://www.sec.gov/Archives/edgar/data/1035422/000155335015001141/0001553350-15-001141-index.htm